DIFFERENTIAL USE OF URICOSURIC DRUGS AND ALLOPURINOL

被引：3

作者：

GROBNER, W ^{[1
]}

ZOLLNER, N ^{[1
]}

机构：

[1] UNIV MUNICH, MED POLIKLIN, D-8000 MUNICH 2, FED REP GER

来源：

KLINISCHE WOCHENSCHRIFT | 1989年 / 67卷 / 05期

关键词：

D O I：

10.1007/BF01892902

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：313 / 315

页数：3

相关论文

共 21 条

[1] KINETICS OF ALLOPURINOL AFTER SINGLE INTRAVENOUS AND ORAL DOSES - NON-INTERACTION WITH BENZBROMARONE AND HYDROCHLOROTHIAZIDE
BREITHAUPT, H
TITTEL, M
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (01) : 77 - 84
[2] KINETICS OF ALLOPURINOL AND OXIPURINOL AFTER CHRONIC ORAL-ADMINISTRATION - INTERACTION WITH BENZBROMARONE
COLIN, JN
FARINOTTI, R
FREDJ, G
TOD, M
CLAVEL, JP
VIGNON, E
DIETLIN, F
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (01) : 53 - 58
[3] DAUL AE, 1984, INTERN PRAXIS, V24, P361
[4] Elion G.B., 1978, URIC ACID, VVolume 51, P485, DOI DOI 10.1007/978-3-642-66867-8_2
[5] ENZYMATIC AND METABOLIC STUDIES WITH ALLOPURINOL
ELION, GB
[J]. ANNALS OF THE RHEUMATIC DISEASES, 1966, 25 (6S) : 608 - &
[6] FRERICK H, 1987, THERAPIEWOCHE, V37, P3379
[7] GROBNER W, 1976, GICHT HDB INNEREN ME, V7, P491
[8] SEVERE ALLOPURINOL TOXICITY - DESCRIPTION AND GUIDELINES FOR PREVENTION IN PATIENTS WITH RENAL-INSUFFICIENCY
HANDE, KR
NOONE, RM
STONE, WJ
[J]. AMERICAN JOURNAL OF MEDICINE, 1984, 76 (01) : 47 - 56
[9] LOFFLER W, 1983, ARZNEIMITTEL-FORSCH, V33-2, P1687
[10] A STUDY OF DOSE-RESPONSE RELATIONSHIPS OF ALLOPURINOL IN THE PRESENCE OF LOW OR HIGH PURINE TURNOVER
LOFFLER, W
GROBNER, W
[J]. KLINISCHE WOCHENSCHRIFT, 1988, 66 (04): : 153 - 159